Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $20.7400 (-3.53%) ($20.2500 - $21.6400) on Thu. Aug. 11, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.96% (three month average) | RSI | 19 | Latest Price | $20.7400(-3.53%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -3.6% a day on average for past five trading days. | Weekly Trend | EDIT declines -8.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) ARKG(60%) IBB(59%) XBI(58%) IWO(55%) ARKK(54%) | Factors Impacting EDIT price | EDIT will decline at least -1.98% in a week (0% probabilities). VIXM(-14%) TLT(-6%) SHY(-6%) IPO(-4%) GDXJ(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.98% (StdDev 3.96%) | Hourly BBV | 0 () | Intraday Trend | -3.8% | | | |
|
1 - 5 Day Possible Target | $10.23(-50.68%) | Resistance Level | $25.03 | 5 Day Moving Average | $22.82(-9.11%) | 10 Day Moving Average | $23.96(-13.44%) | 20 Day Moving Average | $25.03(-17.14%) | To recent high | -44.1% | To recent low | 0% | Market Cap | $1.288b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |